Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet®
Clinical trial NCT06103747 · COMPLETED
Trial details
- NCT number
- NCT06103747
- Sponsor
- Reseach Laboratory of Clinical and Experimental Pharmacology
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2023-08-05
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.